Molnuheal-200mg-Capsule

Molnuheal 200mg Capsule

Therapeutic Class: Anti Infectives
Get Quote

Molnuheal 200mg Capsule is the first oral antiviral medication approved for the treatment of mild to moderate COVID-19 in adults. It works by preventing the virus from replicating, which helps lower the viral load and reduces the severity of the illness. The Indian drug regulatory authorities granted it emergency use authorization on December 28, 2021.

This medication is specifically recommended for adults who have mild to moderate symptoms of COVID-19 and are at high risk of progressing to severe illness. High-risk factors include obesity, age over 60, diabetes, and cardiovascular diseases. Molnuheal is not intended for patients who require immediate hospitalization due to COVID-19. The drug has also received emergency use authorization from the U.S. FDA and the UK’s regulatory agency.

Molnuheal 200mg should be taken orally for no more than five consecutive days. It is crucial to complete the full course of treatment even if symptoms improve before completion. Common side effects may include dizziness, headache, diarrhea, and nausea. Patients experiencing these symptoms should consult their doctor, who may offer supportive treatment or guidance.

Before starting Molnuheal, inform your doctor about any existing medical conditions and current medications to ensure it is safe for you. This medication is not recommended for use during pregnancy, and pregnant or breastfeeding women should consult a healthcare professional before using it.

Salt Composition: Molnupiravir
Strength: 200mg
Pack Size: 40 capsules in 1 bottle
Uses: Herpes labialis Genital herpes infection Chickenpox Herpes Simplex Virus Infections Eye infections by Herpes simplex virus Chronic hepatitis C virus (HCV) infection Treatment of Mild to moderate Coronavirus disease (COVID-19)
Table Header
Salt Composition
Molnupiravir
Strength
200mg
Pack Size
40 capsules in 1 bottle
Uses
Herpes labialis Genital herpes infection Chickenpox Herpes Simplex Virus Infections Eye infections by Herpes simplex virus Chronic hepatitis C virus (HCV) infection Treatment of Mild to moderate Coronavirus disease (COVID-19)
SKU molnuheal200mgcapsule Category
DISCLAIMER
Niche Formulations (www.nicheformulations.com) is WHO GDP and ISO 9001 2015 Certified Pharmaceutical Wholesaler/ Supplier/ Exporters/ Importer from India. Product is supplied for Tenders/ Emergency imports/ Unlicensed, Specials, Orphan drug/ Name patient line/ RLD supplies/ Reference listed drugs/ Comparator Drug/ Bio-Similar/ Innovator samples For Clinical trials. Product names, logos, brands and other trademarks featured or referred to are the property of their respective Trademark Holders. The information provided here is for Informational purposes only.

Product information is meant for

WholesalersSuppliersExportersDoctorsMOH Tender SuppliesHospitalsBrandCROsComparator SuppliesGenericCooperate SourcingIndividual PatientsIndian Institutional Buyers
Recently Viewed
Categories
error:

Select at least 2 products
to compare